1. A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer. (31st March 2015) Authors: Chalasani, Pavani; Marron, Marilyn; Roe, Denise; Clarke, Kathryn; Iannone, Maria; Livingston, Robert B.; Shan, Joseph S.; Stopeck, Alison T. Journal: Cancer medicine Issue: Volume 4:Number 7(2015:Jul.) Page Start: 1051 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer. (5th August 2019) Authors: Segar, Jennifer M.; Reed, Darien; Stopeck, Alison; Livingston, Robert B.; Chalasani, Pavani Journal: Oncologist Issue: Volume 24:Number 12(2019) Page Start: 1512 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Pilot Study of Estradiol Followed by Exemestane for Reversing Endocrine Resistance in Postmenopausal Women With Hormone Receptor-Positive Metastatic Breast Cancer. (26th September 2014) Authors: Chalasani, Pavani; Stopeck, Alison; Clarke, Kathryn; Livingston, Robert Journal: Oncologist Issue: Volume 19:Number 11(2014) Page Start: 1127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Pilot Study of Estradiol Followed by Exemestane for Reversing Endocrine Resistance in Postmenopausal Women With Hormone Receptor‐Positive Metastatic Breast Cancer. (26th September 2014) Authors: Chalasani, Pavani; Stopeck, Alison; Clarke, Kathryn; Livingston, Robert Journal: Oncologist Issue: Volume 19:Number 11(2014) Page Start: 1127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. BAY 94‐9027 prophylaxis is efficacious and well tolerated for up to >5 years with extended dosing intervals: PROTECT VIII extension interim results. Issue 6 (17th October 2019) Authors: Lalezari, Shadan; Reding, Mark T.; Pabinger, Ingrid; Holme, Pal Andre; Negrier, Claude; Chalasani, Pavani; Shin, Ho‐Jin; Wang, Maria; Tseneklidou‐Stoeter, Despina; Maas Enriquez, Monika Journal: Haemophilia Issue: Volume 25:Issue 6(2019) Page Start: 1011 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Circulating Carbonic Anhydrase IX and Antiangiogenic Therapy in Breast Cancer. (28th January 2016) Authors: Brown-Glaberman, Ursa; Marron, Marilyn; Chalasani, Pavani; Livingston, Robert; Iannone, Maria; Specht, Jennifer; Stopeck, Alison T. Other Names: Lichtinghagen Ralf Academic Editor. Journal: Disease markers Issue: Volume 2016(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinicopathological and Molecular Characteristics of Pleomorphic Invasive Lobular Carcinoma. (23rd November 2020) Authors: Segar, Jennifer M.; Pandey, Ritu; Farr, Kiah J.; Nagle, Raymond; LeBeau, Lauren; Gonzalez, Victor J.; Chalasani, Pavani Other Names: Mathieu Marie-Christine Academic Editor. Journal: International journal of breast cancer Issue: Volume 2020(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Confirmed long‐term safety and efficacy of prophylactic treatment with BAY 94–9027 in severe haemophilia A: final results of the PROTECT VIII extension study. Issue 3 (5th April 2021) Authors: Reding, Mark T.; Pabinger, Ingrid; Holme, Pal Andre; Poulsen, Lone; Negrier, Claude; Chalasani, Pavani; Maas Enriquez, Monika; Wang, Maria; Meijer, Karina; Mancuso, Maria Elisa; Lalezari, Shadan Journal: Haemophilia Issue: Volume 27:Issue 3(2021) Page Start: e347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Differential Chemotherapeutic Sensitivity for Breast Tumors With "BRCAness": A Review. (23rd July 2013) Authors: Chalasani, Pavani; Livingston, Robert Journal: Oncologist Issue: Volume 18:Number 8(2013) Page Start: 909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Investigating keratinocyte growth factor hair serum for the prevention of chemotherapy-induced alopecia. Issue 28 (1st October 2022) Authors: Potluri, Preethika; Paul, Emma Elizabeth; Segar, Jennifer Margaret; Ehsani, Sima; Jiralerspong, Sao; Roe, Denise; Chalasani, Pavani Journal: Journal of clinical oncology Issue: Volume 40:Issue 28(2022)Supplement Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗